VIDEO INTERVIEW

THE EXPANSE

The Human Neuroscience Platform at Campus Biotech in Geneva is strengthening and expanding the panel of tools available to the whole scientific and clinical community with the arrival this year of :

• a MEGIN TRIUX™ neo, the first MEG of Switzerland: https://hnp.fcbg.ch/project/meg-2022/
• a Siemens Healthineers MAGNETOM Terra 7T MRI scanner: https://hnp.fcbg.ch/project/7t-mri/

Benoit Dubuis, director of the Fondation Campus Biotech Geneva, introduce the  two systems and details how they integrate into the existing environment at Campus Biotech:

“Our ambition is to offer the best tools and the best support to ensure that researchers can generate research results on which we can build the future of the medical field.”

Watch the full video here:

Ambition Neurosciences

Neuroimaging as a whole has become today both translational, bridging the gap between the research and the clinic, but also interdisciplinary, by supporting and relying on various skills, such as robotics, Artificial Intelligence, Machine Learning, etc… Our vision at Campus Biotech places multimodal imaging and integrative computational techniques at the very center of this evolution.

In this context, the arrival of the MRI and MEG on Campus are part of the large “Ambition Neurosciences” project, whose aim is to support the objectives of the scientific community using state-of-the-art technology in the field of neuroimaging, in order to meet and go beyond today’s research and clinical standards.

Both the Siemens Healthineers MAGNETOM Terra MRI scanner and the MEGIN TRIUX™ neo are indeed new generation devices, pushing the boundaries of brain – and body – imaging several steps further compared to conventional neuroimaging investigating tools.

As always, the HNP is looking forward to support the projects of our many partners using these systems.